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Pregnancy is a state of physiological condition that brings
about various changes in the oral cavity along with other phys-
iological changes taking place throughout the female body.1
Gingival hyperplasia, gingivitis, pyogenic granulomas and var-
ious salivary alterations are some of the changes commonly
witnessed among pregnant women.2 The role of high levels
of circulating estrogen is well established and associated with
high prevalence of gingivitis and gingival hyperplasia.3
Progesterone in the serum is also seen to be associated with
melasma, presenting a bilateral pigmentation or brown
patches in the mid face region.3,4 A general view of physiolog-
ical changes on body systems during pregnancy is given in
Fig. 1.
Various studies have found evidence linking together poor
maternal oral health, pregnancy outcomes and dental health
of the offspring.5 These may range from preterm delivery
and low birth weight to higher risk of early caries among
infants. Unfortunately, apart from self-maintenance of oral
hygiene, pregnant women face several other barriers in achiev-
ing optimal oral health.6,7 These barriers to seeking dental ser-
vices include lack of knowledge and value, negative oral health
experiences, negative attitudes toward oral health profession-
als and negative attitudes of dental staff toward pregnant
women.8 Similarly, incorrect assumptions, lack of knowledge
or experience often plays a role in the hesitance shown by den-
tists in providing dental care for pregnant women.2 Oral health
promotion, disease prevention, early detection and timely
intervention are crucial aspects for maternal and child oral
health.9 It is widely established that many if not all routineand preventive dental procedures can be safely performed
throughout the period of pregnancy with certain
precautions.4,10
An effective model for conceptualizing the management of
the dental needs of pregnant women is needed. Such a model
should encompass interdisciplinary collaboration between the
medical and dental care professionals in order to improve ser-
vices and referral strategies.5 The following sections address
various facets of management of pregnant patients based on
updated guidelines. These are intended as a resource for young
clinicians to gain knowledge and conﬁdently cater to the needs
of pregnant patients.
2. Common dental problems during pregnancy and management
Like any other system, the oral cavity exhibits a number of
changes during pregnancy (Fig. 2) and thus requires special
attention by the dental care professionals. Below are men-
tioned few common dental problems that pregnant women
face.
2.1. Dental caries
Pregnant women are more prone to tooth decay due to upturn
in the acidic environment of oral cavity, increased consump-
tion of sugary diet and carelessness toward oral health.11
Recurrent vomiting becomes common in pregnancy that
enhances acidic environment leading to progress of carious
pathogens and an increased demineralization making teeth
prone to caries.9,10 Untreated carious lesions increase the inci-
dence of abscess and cellulitis.12
Figure 1 Key physiological change observed in various body systems during pregnancy.
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It is advisable for pregnant women to limit sugary diet, brush
regularly with ﬂuoridated tooth paste and use over the counter
ﬂuoridated mouth rinses to counteract the effect of demineral-
ization due to vomiting. The role of topical applications of
ﬂuoride is well accepted for the prevention of caries.13,14
Fluoride releasing restorative materials such as glass ionomers
can inhibit secondary caries.14–17 In addition, drugs such as
methamphetamine that may further aggravate dental caries
should be avoided.18,19
2.2. Periodontal disease
About 30% of pregnant women suffer from periodontal dis-
eases.19,20 While the role of elevated levels of circulating estro-
gen is well established in higher prevalence of gingivitis and
gingival hyperplasia during pregnancy,3 the association
between pregnancy and oral diseases like periodontitis require
further research. The role of elevated levels of inﬂammatory
markers (i.e. interleukin 6, interleukin 8 and PGE2) has been
found in the amniotic ﬂuid of child bearing women having
periodontal conditions, which is considered to be associated
with premature labor and low birth weight.8,21,22
2.2.1. Management
Recent evidence clearly demonstrates that scaling and root
planning is considered safe during pregnancy and improves
both maternal and neonatal health.8 The management strate-
gies to overcome periodontal disease in pregnant females
embraces vigilant diagnosis by the dental health care profes-sional, root planning/deep scaling and prescribing 0.12% daily
chlorhexidine mouth rinses to limit the progress of disease.
Chlorhexidine is categorized as FDA class B and measured
safe to practice in pregnant women.23
2.3. Gingivitis
Gingivitis or bleeding tender gums is the most common dental
problem and contributes to around 60–70% of pregnant
women. Such conditions are common due to decreased
immune response, hormonal ﬂuctuations of estrogens and pro-
gesterone and changes in normal oral ﬂora.24,25
2.3.1. Management
Commendations to improve the condition may comprise pro-
fessional prophylaxis i.e. scaling, daily ﬂuoridated tooth brush-
ing, ﬂossing and saline mouth rinses should be encouraged that
may help in easing the irritant. In addition, chlorhexidine
mouth rinses may provide added beneﬁt.26,27
2.4. Tooth mobility
Due to hormonal rush mineral changes in lamina dura and dis-
turbance in the periodontal ligament attachment, affect mobil-
ity of teeth leading to periodontal diseases.31,32
2.4.1. Management
This condition can be made reversible if given therapeutic
doses of vitamin C along with removal of local gingival
irritants.28,29
Figure 2 Key oral changes and conditions during pregnancy.
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Tooth erosion, another unwanted dental problem is considered
to be caused by pregnancy induced vomiting. It is understood
that dental erosion can be effectively controlled with the use of
a solution containing sodium bicarbonate that neutralizes the
acid and prevents damages.30 It is advised to consult patient’s
physician and gastroenterologist to control the related medical
conditions.
3. Suitable timings and dental management
To preserve and promote oral health; scaling, polishing and
root planning are recommended at any stage of pregnancy.21,22
However, it is strictly advised to perform general dentistry
procedures (i.e. routine restorations, endodontic therapy and
elective extractions) after fetal organogenesis has taken place
(i.e. in second and third trimester). Extensive and prolonged
dental procedures should be postponed till after delivery.3
All treatment modalities should focus on the prevention of oraldiseases, regular monitoring and management of present
disease (Fig. 3).4. Dental chair positioning and pregnancy
When performing chair side procedures it is of great impor-
tance to make sure that the pregnant patients are seated in
the correct and safe position (Fig. 4). This helps to avoid
any complication such as supine hypotensive syndrome in
the dental chair. For example, if a pregnant lady is seated in
the supine position, there are great chances of progression to
medium hypoxemia and an abnormal arterial oxygen gradient.
Similarly there is a risk of compression of the vena cava and
aorta due to the gravid uterus which may lead to postural
hypotension. Therefore it is important that the dealing dentist
makes her sit in the right position; i.e. either seated with her
right hip elevated 10–12 cm so that the pressure on the vena
cava is reduced or by placing the patient in a 5–15% tilt on
her left side. In case the hypotension is not relieved, the patient
should be asked to acquire a full left lateral position. These
Figure 3 Oral health care measures adopted during pregnancy.
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trimester.2,4,10
5. Pharmacodynamics and pregnancy
Pregnancy is a phase having a high volume of drug distribu-
tion, decline in maximum plasma concentration, shorter
plasma half-life, rise in lipid solubility and rate of clearance.6,31
Such dynamics contribute to an easy access of boundless drugs
through the placenta, therefore compromising the health of the
fetus. In addition these drugs may result in low birth weight,
teratogenicity and further adverse effects leading to miscar-
riage. Therefore during this phase, the use of drugs is not rec-
ommended, especially during the ﬁrst 13 weeks i.e. the ﬁrst
trimester. Due to potential adverse effect of drugs and for a
safer approach, drugs have been categorized based on the risk
and hazards to the fetus.6,31 Food and Drug Administration
(FDA), USA has categorized drugs based on their potential
risk factors during pregnancy (Table 1).
5.1. Analgesics
Analgesics are used for a short or limited span of time to treat,
cure and minimize the hassle of pain. Acetaminophen is the
most common and safest analgesic used in pregnancy and is
categorized in group B by the FDA classiﬁcation.32 The mostreported side effect of acetaminophen is hepatotoxicity. Due to
their availability in different formulations it is advised that a
pregnant woman should not exceed more than 4 grams per
day.32 Other analgesics such as ibuprofen is sorted in category
B classiﬁcation in ﬁrst and second trimesters but changes to
category D in the third trimester as the drug is associated with
lower amniotic ﬂuid, premature heart valve closure and limits
the vaginal opening during labor.23 Dentist should recommend
acetaminophen with codeine or oxycodone but prolonged use
is not suggested as it may result in neonatal depression. In
general, this apparently is not of worry as the dose regimes
are characteristically approved in connotation with dental
treatment.32
5.2. Antibiotics
Most antibiotics permitted by the dentist belongs to category B
of FDA classiﬁcation with exemption of gentamycin and doxy-
cycline both of which ﬁts in to class D (Table 1). Gentamycin is
reported to cause fetal ototoxicity whereas doxycycline and its
derivatives cause tetracycline staining of teeth and has a hostile
effect on developing bones. A ciproﬂoxacin (ﬂuoroquinolones)
broad spectrum antibiotic is commonly prescribed in
periodontal diseases associated with actinobacillus. Recent
developing evidence suggests that this drug is involved in
arthropathy and has severe effects on evolving cartilages and
Figure 4 Schematic presentation of correct dental chair positioning for pregnant patients.
Table 1 FDA risk categories of drug used during pregnancy and their potential risk factors.
Category Risk factors Antibiotics Analgesics Sedative
hypnotics
Local
anesthetics
A Satisfactory well controlled studies on humans showing no
hazard to the fetus
B Studies on animals demonstrating no fetal risk whereas no
well controlled and adequate studies done on pregnant
women
Amoxicillin
Cephalexin
Chlorhexidine
Clindamycin
Erythromycin
Metronidazole
Penicillin
Acetaminophen
Ibuprofen
Lidocaine
Prilocaine
Prednisolone
C Studies on animals establishing fetal hazards no controlled
studies on human beings
Ciproﬂoxacin Codeine with
acetaminophen
Hydrocodone
+ acetaminophen
Propoxyphene
Mepivacaine
D Evidence of risk to the fetus, can be used in exceptional
cases or circumstances
Doxycycline
Tetracycline
(D)
Ibuprofen Barbiturates
Benzodiazepines
X The hazards of using the drug in pregnant women far more
than the beneﬁts
Nitrous oxide (avoided in the ﬁrst trimester as it may result in
neonatal depression and spontaneous abortion)
Oral Health and Pregnancy 143is not recommended in pregnant women.33 Metronidazole clas-
siﬁed in group B is prohibited to be used in ﬁrst trimester as the
drug has teratogenic effects.34
5.3. Local and general anesthetics
Localized use of anesthetics is considered safe when given
properly and in precise dose. Anesthetics such as lidocaineand prilocaine are categorized in class B whereas, mepivacaine,
bupivacaine and epinephrine ﬁts in class C of the FDA classi-
ﬁcation.23 Epinephrine with local anesthetics when adminis-
tered through an intravascular route theoretically may be
associated with insufﬁciency of the utero-placental blood ﬂow
but the reported cases in healthy pregnant women are
1:100,000.35 The concentration of epinephrine in a local anes-
thetic used in dentistry is considered safe provided a check is
Table 2 Drugs and maternal teratogens and possible unde-
sired effects.
Known side-eﬀects
Drugs teratogens
Alcohol Cranio-facial abnormalities, fetal
alcoholic syndrome
Tobacco Brain damage, cleft lip and palate
Cocaine Placental abruption, cognitive delay
Thalidomide Malformation of extremities of new born
Methyl mercury Brain damage, microcephaly
ACE inhibitors Cranio-facial abnormalities
Valproic acid Mental retardation, neural tube eﬀects
Tetracycline Maternal toxicity and discoloration of
tooth
Phenytoin Hypoplastic nails, typical facies
Warfarin Facial dysmorphism, chondrodysplasia
Benzodiazepines/
barbiturates
Cleft lip and palate deformities
Maternal teratogens
Toxoplasmosis Spinal abnormalities, brain dysfunction
Chlamydia Conjunctivitis, pneumonia
Hepatitis B Liver damage
Parvovirus Anemia
Chicken pox Eyes damage
144 M. Naseem et al.kept on the proper aspiration technique and the amount
injected.35 On the other hand when doing elective surgical pro-
cedures under general anesthesia, it is important to keep in
consideration the following aspects in relation to the growing
fetus;
 The fetal oxygenation should be retained by maintaining
maternal PaCO2 and PaO2.
 The use of teratogenic agents should be avoided.
 Premature labor should be prevented.
Nitrous oxide is the anesthetic of choice and most com-
monly used in surgical procedures. Nitrous oxide is not
listed in the FDA classiﬁcation as its use during pregnancy
is still controversial.36 The drug is reported to be involved
in preterm birth, abortions and birth defects. Though the
correct timings of long and extensive surgical procedures
should be delayed till after delivery but if a surgical proce-
dure is to be performed in urgency in pregnant women,
low levels of nitrous oxide should be administered, prophy-
lactic dose of folic acid, methionine and vitamin B12 should
be prescribed during ﬁrst trimester. It is best to avoid N2O
during ﬁrst trimester as the hazards clearly outweigh the
beneﬁts.36–38
6. Oral and dental health management guidelines during
pregnancy
Oral health care management of pregnant patients is consid-
ered to be a very important aspect. It is recommended to assess
patient’s current dental health status and then to educate her
about the expected changes during pregnancy and measures
that can be helpful to avoid pain and distress. The dental
examination and treatment causes no harm to the fetus (during
second and third trimester) in contrast to that if left untreated,
e.g. dental decay may cause infant caries at a later stage.39
Similarly other procedures such as diagnosis, periodontal
treatment, restorations and extractions are of no harm and
are recommended to be performed during the middle trimester
as organogenesis is complete by then.
6.1. First trimester
The ﬁrst trimester is not considered to be an appropriate time
for performing procedures. Organogenesis takes place during
this period and is prone to risk of teratogens. Also the risk
of spontaneous abortions increases. Following guidelines
should be followed during this time:
 The individual should be well educated about the oral
changes taking place.
 Instructions to maintain oral hygiene.
 The treatment should be limited to periodontal prophylaxis
and emergency treatment.
 Avoid routine radiographs.
6.2. Second trimester
 In this trimester the organogenesis phase is complete and
procedures such as emergent dento-alveolar and otherelectives procedures are safe to perform. Recommendations
during this pace include: maintenance of oral hygiene and
plaque control.
 It’s safe to perform scaling, polishing and curettage if
necessary.
 Active oral diseases should be controlled.
 It’s safe to perform elective procedures i.e. root canal,
extraction, restorations.
6.3. Selective radiographs can be taken third trimester
It is appropriate to perform short dental procedures during the
third trimester as there is not signiﬁcant risk to the fetus. How-
ever, there is an increased risk of discomfort to the mother that
can be reduced to a greater extent by proper positioning
(Fig. 4). The recommended time to perform procedures is dur-
ing the middle of the third trimester. The following measures
are recommended during third trimester:
 Maintenance of oral hygiene and plaque control.
 It’s safe to perform scaling, polishing and curettage if
necessary.
 Active oral diseases should be controlled.
 It’s safe to perform elective procedures.
 The radiograph use should be minimized.
 Procedures not to be performed after mid time of the third
trimester.
7. Dental radiations and pregnancy
Current evidence suggests that ‘dental radiography’ is mea-
sured as harmless in child bearing women. The safety directly
rests upon the type and amount of radiations to which the
Oral Health and Pregnancy 145patients is exposed. Special precautionary measures should be
guaranteed for pregnant women (e.g. thyroid collar, lead
apron, and speed ﬁlms) because the risk to the growing fetus
is directly connected to rise in exposure.40 Fetus radiation
exposure over 10 rads is considered to be hazardous and
may contribute to mutation, mental retardation and abnor-
malities of the eyes. It’s uncommon for a single X-ray or col-
lection of investigative X-rays to exceed 5 rads.40 For
instance, the volume of radiation that a baby acquires from
a mother’s dental X-ray is only 0.01 millirads. Since a rad is
equivalent to 1000 millirads, one would have to have 100,000
dental X-rays for the baby to receive just one rad.41
The risk from the X-rays (diagnostic) is very low. The
experts, however, often recommend delaying exposure to radi-
ations until birth. If the dentists require X-rays for any partic-
ular condition, the amount of radiation to the growing fetus
must be well within the safe range.40 Also, every protection
should be taken to reduce radiation contact using shielding
thyroid collars and aprons whenever possible.41,428. Teratology
A teratogen is deﬁned as an agent that causes permanent alter-
ations in the form or function of offspring upon exposure to
the fetus (Table 2).43,44 There is a wide range of medications
that can lead to teratogenic effects and thus can be a reason
to cause both functional and structural birth defects. Potential
teratogenic medications include alcohol, tobacco, cocaine,
thalidomide, methyl mercury, anticonvulsant medications,
warfarin compounds, ACE inhibitors, certain antimicrobials,
retinoids, penicillamine tetracycline, trimethadione, valproic
acid and phenytoin. The period that is considered to be most
prone to teratogens is the embryonic period (ﬁrst trimester).
However, teratogen exposure does not harm much after
development of venerable structures with the exception of
tetracycline that may cause yellow brown discoloration of
deciduous teeth even during the second half of pregnancy.43
9. Conclusions and recommendations
Pregnancy should not be considered as an absolute reason to
defer required dental care. Oral care during pregnancy is very
important and involves the contribution of the patient
herself, dental professionals and physicians. Pregnant patients
must be educated about the importance of maintaining
good oral hygiene, expected changes in the oral cavity and rou-
tine dental visits. Dental health professionals must be aware of
updation of pregnancy related conditions and their
proper management without harming the patient and fetus.
Considering the best level of patient’s care, referral and consul-
tation to patient’s gynecologist’s or physician should be con-
sidered. Drug therapies should be limited and carried out
carefully. It is better to avoid radiography and elective surgery.
Female patients of childbearing age or expecting females
should be screened for caries and oral diseases for timely
management.
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